• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤维母细胞性风湿病:首例伴有多核巨细胞浸润及血铅水平升高的病例。

Fibroblastic rheumatism: the first case with infiltration of multinuclear giant cells and raised blood lead level.

作者信息

Zou X W, Huo J, Wang J M, Yuan J Y, Ma Y Y, Wang Q Y

机构信息

Department of Dermatology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

出版信息

Clin Exp Dermatol. 2015 Apr;40(3):309-12. doi: 10.1111/ced.12542. Epub 2014 Dec 26.

DOI:10.1111/ced.12542
PMID:25545215
Abstract

Fibroblastic rheumatism (FR) is a rare condition characterized by symmetrical polyarthritis and multiple cutaneous nodules. Approximately 30 cases have been reported worldwide to date. Laboratory tests are not particular useful to confirm the disease. Diagnosis is mainly dependent on the characteristic histopathological features: thickened collagen fibres with spindle-shaped cell proliferation in the skin lesion. We report a case of a 48-year-old Chinese man with typical clinical features of FR. In addition to the characteristic histopathological findings, multinuclear giant cell infiltration in skin lesions was detected, in this case. The evaluation of microelements revealed a raised blood lead level) of 129 μg/L (normal range 0-99 μg/L) These two features have never been described in the previous medical literature on FR. Thus, we propose that examining the infiltrated cells in detail in histopathological studies and inspecting the levels of lead and other microelements in the blood may increase our understanding of the pathogenesis of FR.

摘要

纤维母细胞性风湿病(FR)是一种罕见疾病,其特征为对称性多关节炎和多发性皮肤结节。迄今为止,全球报告的病例约有30例。实验室检查对确诊该病并无特别帮助。诊断主要依赖于特征性的组织病理学特征:皮肤病变处胶原纤维增厚并伴有梭形细胞增殖。我们报告一例48岁具有FR典型临床特征的中国男性病例。除了特征性的组织病理学表现外,该病例皮肤病变中还检测到多核巨细胞浸润。微量元素评估显示血铅水平升高至129μg/L(正常范围0 - 99μg/L)。这两个特征在以往关于FR的医学文献中从未有过描述。因此,我们建议在组织病理学研究中详细检查浸润细胞,并检测血液中铅及其他微量元素水平,这可能会增进我们对FR发病机制的理解。

相似文献

1
Fibroblastic rheumatism: the first case with infiltration of multinuclear giant cells and raised blood lead level.纤维母细胞性风湿病:首例伴有多核巨细胞浸润及血铅水平升高的病例。
Clin Exp Dermatol. 2015 Apr;40(3):309-12. doi: 10.1111/ced.12542. Epub 2014 Dec 26.
2
Fibroblastic rheumatism: a case without rheumatological symptoms.纤维母细胞性风湿症:一例无风湿症状的病例。
Acta Derm Venereol. 2002;82(3):200-3. doi: 10.1080/00015550260132505.
3
Fibroblastic rheumatism.纤维母细胞性风湿病
J Clin Rheumatol. 2006 Aug;12(4):201-3. doi: 10.1097/01.rhu.0000231383.50323.b5.
4
Fibroblastic rheumatism.
Clin Exp Dermatol. 2009 Jan;34(1):29-32. doi: 10.1111/j.1365-2230.2008.02748.x.
5
Fibroblastic Rheumatism Versus Variant Disease of Multinucleate Cell Angiohistiocytoma.纤维母细胞性风湿症与多核细胞血管组织细胞瘤的变异型疾病
Am J Dermatopathol. 2020 Feb;42(2):136-139. doi: 10.1097/DAD.0000000000001550.
6
Fibroblastic rheumatism: an addition to fibromatosis.纤维母细胞性风湿病:纤维瘤病的一种附加形式。
Joint Bone Spine. 2011 Oct;78(5):519-21. doi: 10.1016/j.jbspin.2011.03.008. Epub 2011 May 5.
7
Fibroblastic rheumatism.
Arch Dermatol. 1995 Jun;131(6):710-2.
8
The arthropathy of fibroblastic rheumatism.纤维母细胞性风湿症的关节病
Arthritis Rheum. 1997 Jan;40(1):183-7. doi: 10.1002/art.1780400124.
9
Fibroblastic rheumatism: clinical and histologic evolution of cutaneous manifestations.纤维母细胞性风湿病:皮肤表现的临床及组织学演变
J Rheumatol. 1998 Nov;25(11):2261-6.
10
Fibroblastic rheumatism: case report and review of the literature.纤维母细胞性风湿症:病例报告及文献复习
Pediatr Dermatol. 2002 Nov-Dec;19(6):532-5. doi: 10.1046/j.1525-1470.2002.00227.x.

引用本文的文献

1
Systematic review of fibroblastic rheumatism: A case report.纤维母细胞性风湿病的系统评价:一例报告
World J Clin Cases. 2023 Jul 26;11(21):5136-5146. doi: 10.12998/wjcc.v11.i21.5136.
2
Fibroblastic rheumatism: an uncommon arthritis. A case-based review.纤维母细胞性风湿病:一种不常见的关节炎。基于病例的综述。
Rheumatol Int. 2022 Jun;42(6):1097-1103. doi: 10.1007/s00296-021-05004-0. Epub 2021 Oct 5.